Category: Oncology

NanoString Proudly Introduces the new nCounter® Canine IO Panel.

It may have happened to you, as it happened to some of us here at NanoString®: the furry, four-legged trouble-making family member you just can’t stay mad at is sick, and the vet doesn't know what is happening. Tests for...

/ January 5, 2021

SITC in Focus: CAR-T Cell Therapy

The Society for Immunotherapy of Cancer (SITC) held its annual meeting online this year. Notable were the presentations in New Approaches for CAR-T Cell Therapies: Technology Symposium Featuring GeoMx® Digital Spatial Profiler (DSP) and nCounter CAR-T Characterization Panel. Two speakers...

/ December 7, 2020

From an Egyptian Papyrus to the Hallmarks of Cancer: A Journey through the Development of Knowledge in Oncology Research

The word "cancer" was used for the first time in ancient Greece by Hippocrates, often termed the Father of Medicine for his contributions to modern medical practice. Even prior to its naming, descriptions of human cancer can be traced back...

/ September 29, 2020

Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.

Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people you can run into in the hallway. She is also...

/ July 27, 2020

Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.

Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a Lecturer in Molecular Oncology and Protein Science at the University...

/ June 22, 2020